tiprankstipranks
Trending News
More News >
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market

Pasithea Therapeutics Corp (KTTA) Income Statement

Compare
148 Followers

Pasithea Therapeutics Corp Income Statement

Last quarter (Q3 2025), Pasithea Therapeutics Corp's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Pasithea Therapeutics Corp's net income was $-3.04M. See Pasithea Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 15.06K$ 0.00
Gross Profit
$ 0.00$ 0.00$ -5.09K$ -2.21K$ 0.00
Operating Expenses
$ 14.25M$ 15.98M$ 12.58M$ 4.51M$ 61.48K
Depreciation and Amortization
$ 649.03K$ 648.45K$ 5.09K$ 1.38K$ 61.48K
EBITDA
$ -13.60M$ -15.33M$ -11.72M$ -4.51M$ 0.00
Operating Income
$ -14.25M$ -15.98M$ -12.59M$ -4.51M$ -61.48K
Other Income/Expenses
$ 345.38K$ 471.61K$ 861.09K$ 2.33M$ 0.00
Pretax Income
$ -13.90M$ -15.51M$ -11.73M$ -2.17M$ -61.48K
Net Income
$ -13.90M$ -15.96M$ -13.94M$ -2.17M$ -61.48K
Per Share Metrics
Basic EPS
$ -12.69$ -12.65$ -10.34$ -1.89$ -0.06
Diluted EPS
$ -12.69$ -13.01$ -10.34$ -1.89$ -0.06
Weighted Average Shares Outstanding
1.10M 1.26M 1.26M 1.15M 688.92K
Weighted Average Shares Outstanding (Diluted)
1.10M 1.23M 1.26M 1.15M 688.92K
Currency in USD

Pasithea Therapeutics Corp Earnings and Revenue History